RSS
Aimovig
Migraine prevention treatment from Novartis receives European approval
The European Commission (EC) has approved Novartis’ Aimovig (erenumab) for the prevention of migraine in adults experiencing four or more migraines per month. Read more
The top five tweets: From migraines to webinars — what have EPM readers clicked on this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
New preventative migraine treatment from Amgen receives FDA approval
A novel treatment for the prevention of migraines, Aimovig (erenumab-aooe), has received approval from the US Food and Drug Administration (FDA). Read more
